Risk of renal cell carcinoma after hysterectomy
- PMID: 21149759
- DOI: 10.1001/archinternmed.2010.425
Risk of renal cell carcinoma after hysterectomy
Abstract
Background: Hysterectomy is the most common gynecologic operation among women; study findings indicate that hysterectomy is associated with renal cell carcinoma.
Methods: To assess the effects of hysterectomy on the incidence and risk of renal cell carcinoma, we performed a population-based cohort study using data from 184,945 women who had undergone hysterectomy (hereafter referred to as women with hysterectomy) and from 657,288 matched women who had not undergone hysterectomy (hereafter referred to as women without hysterectomy) by linking nationwide Swedish health care registers, including the Swedish Inpatient Register and the Swedish Cancer Register (January 1, 1973, through December 31, 2003). Risk of renal cell carcinoma owing to hysterectomy status was assessed using Cox proportional hazards regression models with hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: The crude incidence rates of renal cell carcinoma were 17.4 cases per 100,000 person-years among women with hysterectomy and 13.1 cases per 100,000 person-years among women without hysterectomy. This corresponded to an adjusted overall HR of 1.50 (95% CI, 1.33-1.69) for renal cell carcinoma among women with hysterectomy vs women without hysterectomy. The risk of renal cell carcinoma was age dependent, and the highest risk was found within 10 years of surgery among women who underwent hysterectomy at age 44 years or younger (HR, 2.36; 95% CI, 1.49-3.75). The overall risk of renal cell carcinoma after hysterectomy was consistently increased and of similar magnitude over the time strata: HR, 1.50 (95% CI, 1.26-1.78) for years 0 to 10; 1.49 (1.22-1.82) for years 11 to 20; and 1.51 (1.05-2.16) for more than 20 years after surgery.
Conclusions: Hysterectomy for benign indications was significantly associated with renal cell carcinoma. Women undergoing the procedure at a young age were at particular risk.
Comment in
-
Increased risk of renal cell carcinoma after hysterectomy: possible causes and implications.Arch Intern Med. 2011 Jul 11;171(13):1214-5; author reply 1215-6. doi: 10.1001/archinternmed.2011.302. Arch Intern Med. 2011. PMID: 21747022 No abstract available.
-
Risk of renal cell carcinoma after hysterectomy: is it all obesity?Arch Intern Med. 2011 Jul 11;171(13):1215; author reply 1215-6. doi: 10.1001/archinternmed.2011.303. Arch Intern Med. 2011. PMID: 21747023 No abstract available.
Similar articles
-
Increased risk of renal cell carcinoma subsequent to hysterectomy.Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):999-1003. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10566555
-
Risk of renal cell carcinoma after hysterectomy: is it all obesity?Arch Intern Med. 2011 Jul 11;171(13):1215; author reply 1215-6. doi: 10.1001/archinternmed.2011.303. Arch Intern Med. 2011. PMID: 21747023 No abstract available.
-
Risk of bilateral renal cell cancer.J Clin Oncol. 2009 Aug 10;27(23):3737-41. doi: 10.1200/JCO.2008.20.6524. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597028
-
[De novo urologic tumors in kidney transplant patients].Actas Urol Esp. 2015 Mar;39(2):122-7. doi: 10.1016/j.acuro.2014.05.002. Epub 2014 Jul 2. Actas Urol Esp. 2015. PMID: 24996779 Review. Spanish.
-
Risk factors for adult renal cell carcinoma.Urol Clin North Am. 2004 May;31(2):237-47. doi: 10.1016/j.ucl.2004.01.004. Urol Clin North Am. 2004. PMID: 15123404 Review.
Cited by
-
Is hysterectomy associated with kidney cancer risk? A meta-analysis of cohort studies.Front Oncol. 2023 Jul 20;13:1181112. doi: 10.3389/fonc.2023.1181112. eCollection 2023. Front Oncol. 2023. PMID: 37546408 Free PMC article.
-
Therapeutic role of uterine-derived stem cells in acute kidney injury.Stem Cell Res Ther. 2022 Mar 12;13(1):107. doi: 10.1186/s13287-022-02789-0. Stem Cell Res Ther. 2022. PMID: 35279204 Free PMC article.
-
What We Know about the Long-Term Risks of Hysterectomy for Benign Indication-A Systematic Review.J Clin Med. 2021 Nov 16;10(22):5335. doi: 10.3390/jcm10225335. J Clin Med. 2021. PMID: 34830617 Free PMC article. Review.
-
Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence.Cancers (Basel). 2021 Sep 13;13(18):4588. doi: 10.3390/cancers13184588. Cancers (Basel). 2021. PMID: 34572815 Free PMC article. Review.
-
Long-term intermittent pharmacological therapy of uterine fibroids - a possibility to avoid hysterectomy and its negative consequences.Prz Menopauzalny. 2016 Mar;15(1):48-51. doi: 10.5114/pm.2016.58774. Epub 2016 Mar 29. Prz Menopauzalny. 2016. PMID: 27095959 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
